Your browser doesn't support javascript.
loading
Gastric neuroendocrine tumor: review and update / Tumor neuroendócrino gástrico: revisão e atualização
Dias, Andre Roncon; Azevedo, Beatriz Camargo; Alban, Luciana Bastos Valente; Yagi, Osmar Kenji; Ramos, Marcus Fernando Kodama Pertille; Jacob, Carlos Eduardo; Barchi, Leandro Cardoso; Cecconello, Ivan; Ribeiro-Jr, Ulysses; Zilberstein, Bruno.
  • Dias, Andre Roncon; Cancer Institute of São Paulo State. BR
  • Azevedo, Beatriz Camargo; Cancer Institute of São Paulo State. BR
  • Alban, Luciana Bastos Valente; Cancer Institute of São Paulo State. BR
  • Yagi, Osmar Kenji; Cancer Institute of São Paulo State. BR
  • Ramos, Marcus Fernando Kodama Pertille; Cancer Institute of São Paulo State. BR
  • Jacob, Carlos Eduardo; Cancer Institute of São Paulo State. BR
  • Barchi, Leandro Cardoso; Cancer Institute of São Paulo State. BR
  • Cecconello, Ivan; Cancer Institute of São Paulo State. BR
  • Ribeiro-Jr, Ulysses; Cancer Institute of São Paulo State. BR
  • Zilberstein, Bruno; Cancer Institute of São Paulo State. BR
ABCD (São Paulo, Impr.) ; 30(2): 150-154, Apr.-June 2017. graf
Article in English | LILACS | ID: biblio-885703
ABSTRACT
ABSTRACT

Introduction:

The frequency of gastric neuroendocrine tumors is increasing. Reasons are the popularization of endoscopy and its technical refinements. Despite this, they are still poorly understood and have complex management.

Aim:

Update the knowledge on gastric neuroendocrine tumor and expose the future perspectives on the diagnosis and treatment of this disease.

Method:

Literature review using the following databases Medline/PubMed, Cochrane Library and SciELO. Search terms were gastric carcinoid, gastric neuroendocrine tumor, treatment. From the selected articles, 38 were included in this review.

Results:

Gastric neuroendocrine tumors are classified in four clinical types. Correct identification of the clinical type and histological grade is fundamental, since treatment varies accordingly and defines survival.

Conclusion:

Gastric neuroendocrine tumors comprise different subtypes with distinct management and prognosis. Correct identification allows for a tailored therapy. Further studies will clarify the diseases biology and improve its treatment.
RESUMO
RESUMO

Introdução:

A frequência de tumores neuroendócrinos gástricos está aumentando. As razões são a popularização da endoscopia e seus refinamentos técnicos. Apesar disso, os gástricos ainda são pouco compreendidos e têm manejo complexo.

Objetivo:

Atualizar os conhecimentos nos tumores neuroendócrinos gástricos e expor as perspectivas futuras no diagnóstico e tratamento.

Método:

Revisão da literatura utilizando as seguintes bases de dados Medline/PubMed, Cochrane Library e SciELO. Os descritores da busca foram carcinóide gástrico, tumor neuroendócrino gástrico, tratamento. Dos artigos selecionados, 38 foram incluídos nesta revisão.

Resultados:

Tumores neuroendócrinos gástricos são classificados em quatro tipos clínicos. A identificação correta do tipo clínico e grau histológico é fundamental, pois a conduta é variável e define a sobrevida.

Conclusão:

Tumor neuroendócrino gástrico possui diferentes subtipos com tratamento e prognóstico distintos. A identificação correta destes e seu entendimento permite o tratamento individualizado. Estudos futuros ajudarão a esclarecer a biologia desta doença e melhorar o tratamento.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Stomach Neoplasms / Neuroendocrine Tumors Type of study: Prognostic study Limits: Humans Language: English Journal: ABCD (São Paulo, Impr.) Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Cancer Institute of São Paulo State/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Stomach Neoplasms / Neuroendocrine Tumors Type of study: Prognostic study Limits: Humans Language: English Journal: ABCD (São Paulo, Impr.) Year: 2017 Type: Article Affiliation country: Brazil Institution/Affiliation country: Cancer Institute of São Paulo State/BR